# Jasper Therapeutics, Inc.: Form 8-K, filed Nov 27, 2019

- Company: [Jasper Therapeutics, Inc.](/companies/jspr.md) (CIK 1788028)
- Form: 8-K
- Filed: 2019-11-27
- Accepted by EDGAR: Nov 27, 2019, 16:10 ET
- Period: 2019-11-22
- Accession: 0001213900-19-024928
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1788028/000121390019024928/f8k112219_amplitudehealth.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1788028/000121390019024928/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1788028/000121390019024928/f8k112219_amplitudehealth.htm

Filed Nov 27, 2019.
Source: SEC EDGAR, the filing index for accession 0001213900-19-024928. Last ingested by Listed: Nov 9, 2026, 17:50 ET. No prices; not investment advice.